Loading...
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial.
St Clair, E William Baer, Alan N Ng, Wan-Fai Noaiseh, Ghaith Baldini, Chiara Tarrant, Teresa K Papas, Athena Devauchelle-Pensec, Valerie Wang, Liangwei Xu, Wenjing
St Clair, E William
Baer, Alan N
Ng, Wan-Fai
Noaiseh, Ghaith
Baldini, Chiara
Tarrant, Teresa K
Papas, Athena
Devauchelle-Pensec, Valerie
Wang, Liangwei
Xu, Wenjing
Advisors
Editors
Other Contributors
Departments
Date
2024-06-05
Date Submitted
Keywords
Autoimmunity
Autoimmune diseases
Autoimmune diseases
Other Subjects
Subject Mesh
Planned Date
Start Date
Collaborators
Principal Investigators
Files
Loading...
PMC11186761.pdf
Adobe PDF, 7.04 MB
Alternative Titles
Publisher
Abstract
Language
en
ISSN
eISSN
1546-170X
ISBN
DOI
10.1038/s41591-024-03009-3
PMID
38839899
PMCID
PMC11186761